About Us

Started in 2020 with one desk.

Designed by someone
who went through it.

Kevin Kim went through schools in Korea, Australia and New Zealand. Finished preclinical at Auckland with an A+. Also studied preclinical at Melbourne and at Yonsei. He prepared for medical admissions, got through them, and then started teaching students on the same path.

One thing became clear from teaching: admissions information ages fast, and most extracurriculars end at words. So in 2020 he opened the company — not just to fix the information, but to build output that actually stays on the record.

Today, 40+ mentors and researchers work alongside him, each hired through a 5-to-1 interview round. People who work in clinics, labs and startups design the student's extracurricular work directly.

Started 2020

Medical-only from day one.

Six Years Running

Yearly admits to ANZ medical, dental, pharmacy, vet.

First-Gen Scholarship

Marking 1,000 cumulative students in 2025. Two first-gen students received ~₩21.9M (NZD 25,334).

Seven
differences.

Did the founder go through admissions himself? Are there real cumulative student numbers? Is the team in contact with practicing doctors? That's what defines a real consultancy.

Category
Other Consultancies
INNOS
Founder Background
  • No premed coursework
  • No university or institutional ties
  • Limited admissions expertise
  • Completed premed with A+
  • Former KBSA class rep and AKSA VP
  • Sits UCAT annually, in contact with MMI examiners
Instructors
  • Undergrad med/dent students
  • Part-time / gig model
  • Hired through 5-to-1 ratio
  • 40+ trained instructors
  • Includes former MMI examiners
Track Record
  • Recently launched, unclear record
  • No cumulative data
  • Operating since 2020
  • 1,400+ cumulative students
  • 20–40 medical admits per year
Materials
  • Instructor-owned materials
  • Publicly available materials
  • Five years of founder-built textbooks and videos
  • Past papers, predicted items, mocks
  • Members-only
Mentor
  • No 1:1 dedicated mentor system
  • 1:1 specialty match
  • Doctors, dentists, pharmacists, vets, nurses
Community
  • No medical-career community
  • Run Clinical Outlook ourselves
  • Community for med students and practitioners
  • Blog and columns
Speakers
  • Few practicing doctors involved
  • NZKMA executives
  • KBSA reps
  • AKSA leadership
  • Former MMI examiners and practicing physicians

Six years.

How a one-person school got here.

2020

INNOS Started

One founder. Medical-only.

2023

Acquired LOUNN Consulting

Brought US-admissions specialist LOUNN in-house. Operates as INNOS IVY.

2025

Three Acquisitions

MinervaPrep, Lee Jung-woo Classroom, Clinical Outlook. 38 medical admits that year — including 7 of 40 at CHA Graduate School of Medicine.

2025

First-Gen Scholarship

Crossed 1,000 cumulative students. Two first-gen students received ~₩21.9M (NZD 25,334).

2026

Favikon Ranking

#2 in Education, #1 in EdTech on Favikon's LinkedIn national rankings. 1,400 cumulative students, 40+ instructors.

Two entities,
students from four countries.

Two corporate entities — Korea and New Zealand. We serve students in AU, NZ, KR, and the US. All consultations by appointment.

HQ · NEW ZEALAND

INNOS Education Limited

ANZ medical, general admissions, global HQ

P270 Sunset Road, Windsor Park, Auckland 0632. Address shared at appointment confirmation.

KOREA

INNOS Korea Entity

Korean medical transfers, MGE, special and overseas-student admissions

Seocho office is back-office only. Student consultations are remote, by appointment.

AUSTRALIA · OPERATIONS

INNOS Australia

Australian medical schools, graduate programs, special admissions

For Australia-based students. Remote consultations by appointment.

USA · OPERATIONS

INNOS IVY

US freshman and transfer admissions, GED/CC pathways

Strengthened after the 2023 LOUNN Consulting acquisition.

innosivy.com

The rest,
in consultation.

KakaoTalk gets the fastest reply.

Cookie notice This site uses essential cookies to keep you logged in and remember your language. See our Privacy Policy for details.
Learn more